Paralen | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Clinical Trials
- Clinical Trials
Drugs in Dev.
News
Blog
Market Place
Login

Paralen
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Paracetamol

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Paracetamol

Contact Supplier

pharmacompass-2-m-2026-04-20

Paralen

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

242 API Suppliers, 80 USDMF, 21 CEP/COS, 17 JDMF, 9 EU WC, 108 KDMF, 105 NDC API, 32 Listed Suppliers

242 API Suppliers
80 USDMF
21 CEP/COS
17 JDMF
9 EU WC
108 KDMF
105 NDC API
32 Listed Suppliers

DEVELOPMENTS

185 Drugs in Development

185 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

3601 FDF Dossiers, 737 FDA Orange Book, 1305 Europe, 311 Canada, 105 Australia, 427 South Africa, 716 Listed Dossiers

3601 FDF Dossiers
737 FDA Orange Book
1305 Europe
311 Canada
105 Australia
427 South Africa
716 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUPPOSITORY;RECTAL - 120MG, SUPPOSITORY;RECTAL - 325MG, SUPPOSITORY;RECTAL - 650MG, SUPPOSITORY;RECTAL - 80MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 325MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 300MG;60MG

SUPPOSITORY;RECTAL - 120MG
SUPPOSITORY;RECTAL - 325MG
SUPPOSITORY;RECTAL - 650MG
SUPPOSITORY;RECTAL - 80MG
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 250MG;250MG;65MG
TABLET;ORAL - 325MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG;15MG
TABLET;ORAL - 300MG;30MG
TABLET;ORAL - 300MG;60MG
TABLET;ORAL - 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 325MG;50MG;40MG
TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Minakem, 1 Evonik, 13 Rochem International Inc, 32 SPI Pharma, 2 Pharm-RX Chemical, 14 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 21 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 14 Kirsch Pharma, 1 Panvo Organics, 2 Cerata Pharmaceuticals LLP, 24 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 19 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 44 BASF, 8 Beneo, 2 Bioplus Life Sciences, 6 CD Formulation, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 4 Finar, 17 Gangwal Chemicals, 4 Gloria Interchem, 2 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 2 JJ Chemicals, 26 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 27 Microlex e.U, 2 Nanjing Bold Chemical, 5 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 12 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 56 Roquette, 22 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

124 Fillers, Diluents & Binders, 76 Thickeners and Stabilizers, 72 Solubilizers, 69 Coating Systems & Additives, 58 Taste Masking, 55 Direct Compression, 55 Topical, 53 Parenteral, 49 Disintegrants & Superdisintegrants, 45 Granulation, 44 Lubricants & Glidants, 38 Film Formers & Plasticizers, 35 Controlled & Modified Release, 30 Emulsifying Agents, 28 Chewable & Orodispersible Aids, 23 API Stability Enhancers, 19 Co-Processed Excipients, 17 Surfactant & Foaming Agents, 10 Rheology Modifiers, 9 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

124 Fillers, Diluents & Binders
76 Thickeners and Stabilizers
72 Solubilizers
69 Coating Systems & Additives
58 Taste Masking
55 Direct Compression
55 Topical
53 Parenteral
49 Disintegrants & Superdisintegrants
45 Granulation
44 Lubricants & Glidants
38 Film Formers & Plasticizers
35 Controlled & Modified Release
30 Emulsifying Agents
28 Chewable & Orodispersible Aids
23 API Stability Enhancers
19 Co-Processed Excipients
17 Surfactant & Foaming Agents
10 Rheology Modifiers
9 Empty Capsules
4 Vegetarian Capsules
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 381 News #PharmaBuzz

3 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
381 News #PharmaBuzz

GLOBAL SALES INFORMATION

94 US Medicaid Prescriptions, 66 Regulatory FDF Prices, 21 Annual Reports

94 US Medicaid Prescriptions
66 Regulatory FDF Prices
21 Annual Reports

MARKET PLACE

201 APIs, 95 FDF Dossiers

201 APIs
95 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 2 US Exclusivities, 7 Health Canada Patents

41 US Patents
2 US Exclusivities
7 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 JP, 36 Others

1 EDQM
1 JP
36 Others

ANALYTICAL

2 BioAnalytical Methods, 8 Analytical Methods

2 BioAnalytical Methods
8 Analytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

7 All

01 1AFT PHARMS US

02 1AM REGENT

03 1BAXTER HLTHCARE CORP

04 4HONG KONG

filter Product Reset all filters

7 All

01 1ACETAMINOPHEN

02 1ACETAMINOPHEN; IBUPROFEN

03 1FERRIC CARBOXYMALTOSE

04 4LEFAMULIN ACETATE

filter Exclusivity Expiration Date Reset all filters

7 All

01 22024-08-19

02 12026-01-07

03 12026-03-01

04 12026-05-31

05 22029-08-19

filter Exclusivity Code Reset all filters

7 All

01 2GAIN

02 1I-915

03 2NCE

04 1NP

05 1PC

Granules Paracetamol

Product Main Page

AFT PHARMS US

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ACETAMINOPHEN; IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2026-03-01

Application Number

209471

Product Number

1

Exclusivity Details

01

AFT PHARMS US

ACETAMINOPHEN; IBUPROFEN

PEGS Boston Summit

Not Confirmed

AFT PHARMS US

New Zealand

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ACETAMINOPHEN; IBUPROFEN

Exclusivity Code : NP

Exclusivity Expiration Date : 2026-03-01

Application Number : 209471

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BAXTER HLTHCARE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ACETAMINOPHEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PC

Exclusivity Expiration Date

2026-01-07

Application Number

214331

Product Number

2

Exclusivity Details

02

BAXTER HLTHCARE CORP

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE CORP

U.S.A

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ACETAMINOPHEN

Exclusivity Code : PC

Exclusivity Expiration Date : 2026-01-07

Application Number : 214331

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HONG KONG

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

LEFAMULIN ACETATE

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

GAIN

Exclusivity Expiration Date

2029-08-19

Application Number

211672

Product Number

1

Exclusivity Details

03

HONG KONG

LEFAMULIN ACETATE

PEGS Boston Summit

Not Confirmed

HONG KONG

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEFAMULIN ACETATE

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2029-08-19

Application Number : 211672

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

HONG KONG

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

LEFAMULIN ACETATE

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

GAIN

Exclusivity Expiration Date

2029-08-19

Application Number

211673

Product Number

1

Exclusivity Details

04

HONG KONG

LEFAMULIN ACETATE

PEGS Boston Summit

Not Confirmed

HONG KONG

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEFAMULIN ACETATE

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2029-08-19

Application Number : 211673

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

HONG KONG

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

LEFAMULIN ACETATE

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2024-08-19

Application Number

211673

Product Number

1

Exclusivity Details

05

HONG KONG

LEFAMULIN ACETATE

PEGS Boston Summit

Not Confirmed

HONG KONG

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEFAMULIN ACETATE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2024-08-19

Application Number : 211673

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

HONG KONG

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

LEFAMULIN ACETATE

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2024-08-19

Application Number

211672

Product Number

1

Exclusivity Details

06

HONG KONG

LEFAMULIN ACETATE

PEGS Boston Summit

Not Confirmed

HONG KONG

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

LEFAMULIN ACETATE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2024-08-19

Application Number : 211672

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

AM REGENT

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

FERRIC CARBOXYMALTOSE

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

I-915

Exclusivity Expiration Date

2026-05-31

Application Number

203565

Product Number

4

Exclusivity Details

07

AM REGENT

FERRIC CARBOXYMALTOSE

PEGS Boston Summit

Not Confirmed

AM REGENT

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FERRIC CARBOXYMALTOSE

Exclusivity Code : I-915

Exclusivity Expiration Date : 2026-05-31

Application Number : 203565

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.